Active	Status	Sponsor type	Region	Phase	Filter
20 Active 0 Inactive 20 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lan, Xiaoli
NCT05542953: [18F]APN-1607 PET in Subjects With AD Compared to HC	Recruiting	3	230	RoW	[18F]APN-1607	APRINOIA Therapeutics	Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers	06/23	06/23
NCT06750419: 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study	Recruiting	3	82	RoW	89Zr-TLX250 PET/CT, 89Zr-DFO-girentuximab, 89Zr-girentuximab, 89Zr-DFO-TFP-GTX, 89Zirconium-labelled girentuximab	Telix Pharmaceuticals (Innovations) Pty Limited	Clear Cell Renal Cell Carcinoma	06/26	06/26
NCT05847348: 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients	Recruiting	3	110	RoW	68Ga-PSMA-11, Illucix, gallium Ga 68 Gozetotide, PET/CT or PET/MRI, Imaging by PET	Telix Pharmaceuticals (Innovations) Pty Limited, Grand Pharmaceutical (China) Co., Ltd.	Biochemical Recurrence of Malignant Neoplasm of Prostate, Prostate Cancer, BCR Prostate Carcinoma	12/25	07/26